![Elite Pharmaceuticals, Inc. logo](/logos/ELTP.webp)
Elite Pharmaceuticals, Inc.
OTC:ELTP
Overview | Financials
Company Name | Elite Pharmaceuticals, Inc. |
Symbol | ELTP |
Currency | USD |
Price | 0.152 |
Market Cap | 154,115,840 |
Dividend Yield | 0% |
52-week-range | 0.03 - 0.17 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Nasrat Hakim |
Website | https://www.elitepharma.com |
An error occurred while fetching data.
About Elite Pharmaceuticals, Inc.
Elite Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and manufacture of oral, controlled-release products and generic pharmaceuticals. The company operates in two segments, Abbreviated New Drug Applications for Generic Products and New Drug Applications for Branded Products. It owns, licenses, and contract manufactures various generic and oral
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD